Do national medicinal drug policies and essential drug programs improve drug use?: A review of experiences in developing countries

Social Science and Medicine

Volumn 53, Issue 7, 2001, Pages 831-844

  Ratanawijitrasin, Sauwakon ^a   Soumerai, Stephen B ^b   Weerasuriya, Krisantha ^c  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

Access; Drug policy; Drug regulation; Essential drug program; Policy evaluation; Rational drug use

Indexed keywords

DRUG USER; HEALTH POLICY; NATIONAL STRATEGY; POLICY DEVELOPMENT;

COST; DEVELOPING COUNTRY; DRUG PROGRAM; DRUG USE; EXPERIENCE; INFORMATION CENTER; PHARMACY; POLICY; PRIMARY MEDICAL CARE; PUBLICATION; REGULATORY MECHANISM; REVIEW;

EID: 0034899335     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(00)00390-7     Document Type: Short Survey

References (41)

1. Assessing the impact of a regulatory intervention in Pakistan
2. Lessons from international experience in controlling pharmaceutical expenditure III: Regulating industry
3. Effect of a drug supply & cost sharing system on prescribing & utilization: A controlled trail from Nepal
4. A national program for control of acute respiratory tractinfections: The Philippine experience
5. Effect of diarrhoeal disease control on infant and childhood mortality in Egypt. Report from the National CDD Project
6. The role and experience of the World Health Organization in assisting countries to develop and implement national drug policies
7. Impact of an essential drugs programme on availability and rational use of drugs
8. Use and abuse of benzodiazepines in Hong Kong 1990-1993 - The impact of regulatory changes
9. Managing essential drug supplies to rural health by UNICEF Uganda
10. Food and drug administration
11. A strategy for promoting improved pharmaceutical use: The international network for rational use of drugs
12. Improving pharmaceutical use in primary care in developing countries: A critical review of experience and lack of experience
13. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia
14. A critical analysis of studies of state drug reimbursement policies: Research in need of discipline
15. Withdrawing payment for nonscientific drug therapy: Intended and unexpected effects of a large-scale natural experiment
16. Evaluation of rational drug prescribing in Democratic Yemen
17. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations
18. Evaluation of the ministry of public health's generic labeling and advertising policy
19. Sri Lanka: The impact of allowing paramedical prescription and resupply of oral contraceptives